|
|
|
|
| LEADER |
01000caa a2200265 4500 |
| 001 |
OLC1983578703 |
| 003 |
DE-627 |
| 005 |
20230511123948.0 |
| 007 |
tu |
| 008 |
161013s2017 xx ||||| 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.bbrc.2016.08.043
|2 doi
|
| 028 |
5 |
2 |
|a PQ20170301
|
| 035 |
|
|
|a (DE-627)OLC1983578703
|
| 035 |
|
|
|a (DE-599)GBVOLC1983578703
|
| 035 |
|
|
|a (PRQ)crossref_primary_10_1016_j_bbrc_2016_08_0430
|
| 035 |
|
|
|a (KEY)0391486020170000483000401166peroxisomeproliferatoractivatedreceptorspparsasthe
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 570
|q DNB
|
| 084 |
|
|
|a BIODIV
|2 fid
|
| 084 |
|
|
|a WA 15000
|q AVZ
|2 rvk
|
| 084 |
|
|
|a 35.70
|2 bkl
|
| 084 |
|
|
|a 42.12
|2 bkl
|
| 100 |
1 |
|
|a Agarwal, Swati
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders
|
| 264 |
|
1 |
|c 2017
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 700 |
1 |
|
|a Yadav, Anuradha
|4 oth
|
| 700 |
1 |
|
|a Chaturvedi, Rajnish Kumar
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|t Biochemical and biophysical research communications
|d San Diego, Calif. : Elsevier, 1959
|g 483(2017), 4, Seite 1166-1177
|w (DE-627)129488798
|w (DE-600)205723-2
|w (DE-576)014881640
|x 0006-291X
|7 nnns
|
| 773 |
1 |
8 |
|g volume:483
|g year:2017
|g number:4
|g pages:1166-1177
|
| 856 |
4 |
1 |
|u http://dx.doi.org/10.1016/j.bbrc.2016.08.043
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_OLC
|
| 912 |
|
|
|a FID-BIODIV
|
| 912 |
|
|
|a SSG-OLC-CHE
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OLC-DE-84
|
| 912 |
|
|
|a GBV_ILN_21
|
| 912 |
|
|
|a GBV_ILN_70
|
| 912 |
|
|
|a GBV_ILN_2219
|
| 936 |
r |
v |
|a WA 15000
|
| 936 |
b |
k |
|a 35.70
|q AVZ
|
| 936 |
b |
k |
|a 42.12
|q AVZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 483
|j 2017
|e 4
|h 1166-1177
|
